Regorafenib (BAY 73-4506)
Regorafenib(BAY 73-4506)是一种多激酶抑制剂,其IC50分别为17、40和69 nM的c-KIT、VEGFR2、B-Raf。Regorafenib(BAY 73-4506)是一种口服生物可用的多激酶抑制剂,针对肿瘤及其血管系统。
全国免运费, 顺丰次日达
重要通知:仅供研究使用。我们不向患者销售。
重要通知:仅供研究使用。我们不向患者销售。
Discription | Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. Regorafenib (BAY 73-4506) is an orally bioavailable multikinase inhibitor targeting both the tumor and its vasculature. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A10250 |
---|---|
分子式 | C21H15ClF4N4O3 |
分子量 | 482.8 |
CAS号 | 755037-03-7 |
SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 88 mg/mL (182.26 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+30% PEG 300+5% Tween 80+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.71 mL | 103.56 mL | 207.13 mL |
0.5 mM | 4.14 mL | 20.71 mL | 41.43 mL |
1 mM | 2.07 mL | 10.36 mL | 20.71 mL |
5 mM | 0.41 mL | 2.07 mL | 4.14 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2